JavaScript seems to be disabled in your browser. You must have JavaScript enabled in your browser to utilize the functionality of this website.
Description: Toceranib (formerly known as PHA-291639, or SU 11654) is an inhibitor of receptor tyrosine kinase (RTK) with Ki values of 6 nM and 5 nM for Flk-1/KDR and PDGFRbeta, respectively. It is used in the treatment of canine mast cell tumor (also called mastocytoma). Toceranib is an veterinary drug that was approved for use in dog. Toceranib is likely to act mostly through inhibition of the kit tyrosine kinase, though it may also have an anti-angiogenic effect.
References: J Vet Intern Med. 2012 Mar-Apr; 26(2):355-62; BMC Vet Res. 2014 May 6; 10:105.
Related CAS#:874819-74-6 (phosphate)
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.
Request Data Sheet
Request product datasheet
Request safety datasheet
Compare
Add to wishlist
Get an offer
Request delivery time
Ask a technical question
Submit a bulk request
sales@hoelzel.de
« Back
Subscribe, get 15% off every fifth order and have your items delivered on time!
Forgot Your Password?
Not yet registered? Create account here!